Vivid Vision is a San Francisco medical technology company that turns virtual reality headsets into tools for vision care. Founded in 2014 by programmer James Blaha, who built the first prototype to treat his own lazy eye, the company started with VR games for amblyopia and strabismus and now runs two lines: a clinical and at-home vision therapy suite used in clinics across 50+ countries, and Vivid Vision Perimetry (VVP), a VR-based visual field test being adopted as a digital endpoint in pharmaceutical clinical trials for glaucoma, AMD, and geographic atrophy.
Luminopia is a commercial-stage digital therapeutics company that turns a child's favorite TV shows into FDA-cleared medicine for amblyopia (lazy eye). Children wear a VR headset for one hour a day, six days a week, and watch curated, real-time-modified episodes that retrain the brain to use both eyes together. Founded by Harvard dropouts and incubated at Boston Children's Hospital, Luminopia One became the first FDA-approved digital therapeutic for a neuro-visual disorder.
Scott Xiao is the co-founder and CEO of Luminopia, a Boston-area digital therapeutics company whose lead product turns watching cartoons in a VR headset into an FDA-approved treatment for amblyopia, the leading cause of vision loss in children. He left Harvard with classmate Dean Travers to build the first VR-based therapeutic ever cleared by the FDA, partnering with Sesame Workshop, Nickelodeon, and DreamWorks for content and with Boston Children's Hospital and MIT for the science.